Page 231 - Clinical Small Animal Internal Medicine
P. 231

199


  VetBooks.ir






               20


               Ventricular Arrhythmias
                                                     1
               Amara H. Estrada, DVM, DACVIM (Cardiology)  and Romain Pariaut, DVM, DACVIM (Cardiology),
               DECVIM-CA (Cardiology) 2
               1  Department of Small Animal Clinical Sciences, University of Florida, Gainesville, FL, USA
               2  Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA


                 Etiology/Pathophysiology                         appears that in dogs and cats with VPCs and no underlying
                                                                  heart disease, the number of VPCs is not predictive of the
               Ventricular arrhythmias (VA) such as single ventricular   risk of sudden death, which in this setting is typically low.
               premature depolarizations (contractions) (VPCs) can be   When there is underlying myocardial disease, the presence
               seen in normal animals in low numbers (less than 50 per   of VPCs may indicate an increased risk of sudden death or
               24‐hour period on a Holter monitor). They are very com-  simply be a marker for the severity of the disease (for exam-
               monly seen in association with noncardiac disease, pos-  ple, Doberman pinschers with dilated cardiomyopathy or
               sibly due to myocardial ischemia, electrolyte abnormalities   cats with hypertrophic cardiomyopathy). The presence of
               or other factors surrounding the underlying disease. For   VPCs in boxers with familial ventricular arrhythmias may
               example, VPCs can be seen following vehicular trauma   indicate an increased risk of sudden death.
               (traumatic myocarditis), surgery, gastric dilation and vol-
               vulus, splenic disease, immune‐mediated hemolytic ane-    Signalment
               mia and/or polycythemia, hypoxia, the use of anesthetic
               agents (especially thiobarbiturates), pancreatitis, prosta-  Certain breeds with specific underlying cardiac diseases are
               titis, and neurologic disease. Thus, ventricular arrhyth-  predisposed to malignant VA. Doberman pinschers with
               mias are relatively common to any number of different   dilated cardiomyopathy, boxers with arrhythmogenic right
               systemic diseases. They may also be associated with   ventricular cardiomyopathy, dogs with severe subaortic ste-
                 primary underlying myocardial diseases such as dilated   nosis, young German shepherds with  inherited ventricular
               cardiomyopathy in Doberman pinschers and arrhythmo-  arrhythmias, dogs and cats with myocarditis and cats with
               genic right ventricular cardiomyopathy in boxers. They   hypertrophic cardiomyopathy represent situations where a
               can also be idiopathic in origin, meaning that no underly-  VA may signal increased risk for clinical signs or sudden
               ing systemic or cardiac disorder can be identified.  death. Other than the specific patient groups and underly-
                 The most important clinical considerations with VPCs   ing type of cardiac diseases mentioned above, there is no
               are  whether  there is  an  underlying  systemic or  cardiac   other specific age, breed or sex predilection
               cause of the VPCs and whether there is the need to treat
               the VA. Decisions to treat VA should be based on hemody-
               namic consequences and the risk of degeneration of the VA     History and Clinical Signs
               into an unstable rhythm such as ventricular fibrillation.
               Single VPCs do not cause clinical signs as they are transient   Dogs with VA secondary to systemic disease often do not
               and  hemodynamically not significant.  What is  more   need the VA to be treated as the arrhythmia tends to be
               important is attempting to identify malignant characteris-  self‐limiting if the underlying disease is addressed. For
               tics of VPCs or patient groups that might be more suscep-  example, a patient with VPCs and gastric dilation‐volvu-
               tible to the development of an unstable rhythm that can   lus does not necessarily require antiarrhythmic therapy
               lead to sudden death. However, our ability to predict the   for the VPCs, and instead needs relief of the dilation and
               likelihood of sudden death associated with VPCs is poor. It   volvulus. This will in turn lead to resolution of the



               Clinical Small Animal Internal Medicine Volume I, First Edition. Edited by David S. Bruyette.
               © 2020 John Wiley & Sons, Inc. Published 2020 by John Wiley & Sons, Inc.
               Companion website: www.wiley.com/go/bruyette/clinical
   226   227   228   229   230   231   232   233   234   235   236